Austar Lifesciences (Austar Lifesciences) Additional Paid-In Capital : $47.6 Mil(As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Austar Lifesciences Additional Paid-In Capital?

Austar Lifesciences's quarterly additional paid-in capital declined from Dec. 2022 ($48.7 Mil) to Jun. 2023 ($47.3 Mil) but then increased from Jun. 2023 ($47.3 Mil) to Dec. 2023 ($47.6 Mil).

Austar Lifesciences's annual additional paid-in capital increased from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($48.7 Mil) but then declined from Dec. 2022 ($48.7 Mil) to Dec. 2023 ($47.6 Mil).

Austar Lifesciences Additional Paid-In Capital Historical Data

The historical data trend for Austar Lifesciences's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Austar Lifesciences Additional Paid-In Capital Chart

Austar Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

48.71

47.56

Austar Lifesciences Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															-	-	48.71	47.34	47.56

Austar Lifesciences Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Austar Lifesciences Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Austar Lifesciences's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Austar Lifesciences (Austar Lifesciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Austar Lifesciences Ltd (OTCPK:AULSF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

06118:Hong Kong

Address

No. 1018, Changning Road, Rooms 2010-2013, 20th Floor, Changning District, Shanghai, CHN

Website

https://www.austar.com.hk

Austar Lifesciences Ltd is a China-based company engaged in providing engineering solutions to pharmaceutical manufacturers and research institutes. The business activity of the group is operated through Liquid and Bioprocess Systems; Clean Room and Automation Control and Monitoring Systems; Powder and Solid Systems; Good Manufacturing Practice (GMP) Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment segments. It derives the majority of revenue from the Liquid and Bioprocess System segment which is involved in providing solutions in pharmaceutical and water systems to treat water. The geographical business presence of the firm is seen across China and in other countries.

Austar Lifesciences (Austar Lifesciences) Headlines

No Headlines